[1]Chen W，Zheng R，Zeng H，et al．Annual report on status of cancer in China，2011．Chin J Cancer Res，2015，27（1）：2-12．

[2]Herbertson RA，Scarsbrook AF，Lee ST，et al．Established，emerging and future roles of PET/CT in the management of colorectal cancer．Clin Radiol，2009，64：225-237．

[3]Maas M，Rutten IJ，Nelemans PJ，et al．What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer？A meta-analysis．Eur J Nucl Med Mol Imaging，2011，38：1560-1571．

[4]Kwak JY，Kim JS，Kim HJ，et al．Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer．World J Surg，2012，36：1898-1905．

[5]Muralidharan V，Kwok M，Lee ST，et al．Prognostic ability of ¹⁸F-FDG PET/CT in the assessment of colorectal liver metastases．J Nucl Med，2012，53：1345-1351．

[6]Lu YY，Chen JH，Chien CR，et al．Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA：a systematic review and meta-analysis．Int J Colorectal Dis，2013，28：1039-1047．

[7]胡珊山，吴湖炳，王全师，等． ¹⁸F-FDG PET/CT显像对结直肠癌术后复发及转移的诊断价值．核技术，2011，34：217-221．

[8]Han A，Xue J，Zhu D，et al．Clinical value of ¹⁸F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma．Cancer Epidemiology，2011，35：497-500．

[9]Necib H，Garcia C，Wagner A，et al．Detection and characterization of tumor changes in ¹⁸F-FDG PET patient monitoring using parametric imaging．J Nucl Med，2011，52：354-361．

[10]NCCN Clinical Practice Guidelines in Oncology（NCCN Guidelines ^Ⓡ）．Colon cancer V．3．2014．

[11]李玲，徐瑾，张自成，等． ¹⁸FDG SUV值对直肠癌预测价值的探讨．中华肿瘤防治杂志，2009，16：1594-1596．